Childhood Acute Leukemias in Developing Nations: Successes and Challenges
- PMID: 33755790
- DOI: 10.1007/s11912-021-01043-9
Childhood Acute Leukemias in Developing Nations: Successes and Challenges
Abstract
Purpose of review: Acute leukemias represent a tremendous threat to public health around the globe and the main cause of death due to disease in scholar age children from developing nations. Here, we review their current status in Mexico, as a paradigm of study, and the major challenges to control systemic diseases like childhood cancer.
Recent findings: A unique molecular epidemiology, late/low precision diagnosis, limited access to treatment, toxicity associated with therapy, continuous exposure to environmental risk factors, and the high frequency of early relapses are some of the factors cooperating to low rates of survival in low-to-medium-income countries. Deliberative dialogues and exhaustive programs have emerged as promising means of advancing evidence-informed policy, by providing a structured forum for key stakeholders to integrate scientific and pragmatic knowledge about complex health concerns. A system-wide strategy based on the comprehensive leukemia identity is essential for a meaningful decline in early childhood mortality.
Keywords: Acute lymphoblastic leukemia; Bone marrow; Childhood cancer; Leukemia burden; Leukemia stratification; Leukemia-initiating cells; Low-to-middle-income countries; Systemic diseases; Tumor microenvironment.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- WHO 2020: Regional Office for the Americas of the World Health Organization 525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America, 2020.
-
- International Agency for Research on Cancer. GLOBOCAN: estimated cancer incidence, mortality and prevalence worldwide in 2018. Lyon, France: IARC; 2018 http://globocan.iarc.fr/ .
-
- Steliarova-Foucher E. How can global incidence estimates support childhood cancer control? Lancet Oncol. 2019;20:460–1. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
